Literature DB >> 22179099

Oncogenic osteomalacia, raised FGF-23, and renal Fanconi syndrome.

A G W Norden1, R J C Laing, P Rowe, R J Unwin, O Wrong, A J Crisp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22179099      PMCID： PMC3916735          DOI： 10.1093/qjmed/hcr247

Source DB:  PubMed          Journal:  QJM        ISSN： 1460-2393


× No keyword cloud information.
  10 in total

1.  Four cases of acquired hypophosphataemic ('oncogenic') osteomalacia. Problems of diagnosis, treatment and long-term management.

Authors:  G P Clunie; P E Fox; T C Stamp
Journal:  Rheumatology (Oxford)       Date:  2000-12       Impact factor: 7.580

2.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

3.  Tubular proteinuria defined by a study of Dent's (CLCN5 mutation) and other tubular diseases.

Authors:  A G Norden; S J Scheinman; M M Deschodt-Lanckman; M Lapsley; J L Nortier; R V Thakker; R J Unwin; O Wrong
Journal:  Kidney Int       Date:  2000-01       Impact factor: 10.612

4.  A loss-of-function mutation in NaPi-IIa and renal Fanconi's syndrome.

Authors:  Daniella Magen; Liron Berger; Michael J Coady; Anat Ilivitzki; Daniela Militianu; Martin Tieder; Sara Selig; Jean Yves Lapointe; Israel Zelikovic; Karl Skorecki
Journal:  N Engl J Med       Date:  2010-03-25       Impact factor: 91.245

Review 5.  Endocrine functions of bone in mineral metabolism regulation.

Authors:  L Darryl Quarles
Journal:  J Clin Invest       Date:  2008-12-01       Impact factor: 14.808

6.  Age, renal tubular phosphate reabsorption, and serum phosphate levels in adults.

Authors:  Massimo Cirillo; Carolina Ciacci; Natale G De Santo
Journal:  N Engl J Med       Date:  2008-08-21       Impact factor: 91.245

7.  Osteomalacia due to 1alpha,25-dihydroxycholecalciferol deficiency. Association with a giant cell tumor of bone.

Authors:  M K Drezner; M N Feinglos
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

8.  Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia.

Authors:  Yasuo Imanishi; Jun Hashimoto; Wataru Ando; Keisuke Kobayashi; Takafumi Ueda; Yuki Nagata; Akimitsu Miyauchi; Hajime M Koyano; Hiroshi Kaji; Takatoshi Saito; Koichi Oba; Yasato Komatsu; Tomoaki Morioka; Katsuhito Mori; Takami Miki; Masaaki Inaba
Journal:  J Bone Miner Metab       Date:  2011-07-08       Impact factor: 2.626

9.  Distinctive tumours of bone and soft tissue causing acquired vitamin-D-resistant osteomalacia.

Authors:  D J Evans; J G Azzopardi
Journal:  Lancet       Date:  1972-02-12       Impact factor: 79.321

10.  Fanconi syndrome associated with a non-ossifying fibroma of bone.

Authors:  D J Leehey; T S Ing; J T Daugirdas
Journal:  Am J Med       Date:  1985-04       Impact factor: 4.965
  10 in total
  2 in total

1.  CT and MR imaging features in phosphaturic mesenchymal tumor-mixed connective tissue: A case report.

Authors:  Zhenshan Shi; Yiqiong Deng; Xiumei Li; Yueming Li; Dairong Cao; Vikash Sahadeo Coossa
Journal:  Oncol Lett       Date:  2018-02-05       Impact factor: 2.967

2.  Osteomalacia, renal Fanconi syndrome, and bone tumor.

Authors:  Manting Gou; Zhongshu Ma
Journal:  J Int Med Res       Date:  2018-04-03       Impact factor: 1.671
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.